BRUSSELS, May 28 (Reuters) - European Union competition
regulators approved on Tuesday a 1.4-billion-euro ($1.52
billion) hydrogen schemed to be funded by seven EU countries
which they expect to unlock an additional 3.3 billion euros in
private investments.
The regulators also approved a separate 1-billion-euro
healthcare scheme to be funded by six other EU countries.
Estonia, France, Germany, Italy, Netherlands, Slovakia and
Spain will fund the hydrogen scheme, the European Commission
said in a statement.
It said 11 companies, including Airbus, BMW
and Michelin, will take part in 13 projects
under the scheme.
This is the fourth such joint hydrogen scheme cleared by the
Commission which also acts as the EU competition enforcer.
The healthcare scheme will be funded by Belgium, France,
Hungary, Italy, Slovakia and Spain to support research and
innovation and is expected to unlock an additional 5.9 billion
euros in private investments, the Commission said.
Sanofi, Euroapi and 11 other companies
will participate in 14 healthcare projects, which include
studying cells and tissues, sustainable production technologies
of breakthrough therapies and application of advanced digital
technologies.
Both schemes fall under a so-called Important Project of
Common European Interest (IPCEI) which allows EU governments to
fund them under looser EU state aid rules.
Participating companies which generate extra net revenue
from the projects will have to return part of the state aid they
received under a claw back mechanism.
Commission Vice President Margrethe Vestager said IPCEI
projects were part of the EU's drive to spur its
competitiveness.
"The Commission has approved a total of aid of more than 37
billion euros. These public investments, well they have
attracted 66 billions of euros in additional private
investment," she told a press conference.
"So in total this means more than 100 billion euros in
investment to foster the competitiveness of European industry,"
Vestager said.
($1 = 0.9193 euros)
(Reporting by Foo Yun Chee; Editing by Emelia Sithole-Matarise)